InnovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator's choice of chemotherapy in 2L or 3L recurrent or metastatic cervical cancer

Fujiwara, K ; Slomovitz, BM ; Gonzalez Martin, A ; Kalbacher, E ; Bagameri, A ; Ghamande, S ; Lee, J-Y ; Banerjee, S ; Maluf, FC ; Lorusso, D ; Yonemori, K ; van Nieuwenhuysen, E ; Manso Sanchez, LM ; Woelber, L ; Westermann, AM ; Covens, A ; Whalley, E ; Teng, MSL ; Soumaoro, I ; Vergote, IB

ELSEVIER

Texto completo disponível

Updated Interim Results of the Clinical Performance Evaluation of a Novel Deep Learning Solution for Homologous Recombination Deficiency Detection

Buisson, A ; Saintigny, P ; Harle, A ; Vacirca, D ; Barberis, M ; Gilson, P ; Roma, C ; Bergantino, F ; Grimm, C ; Muellauer, L ; Harter, P ; Pignata, S ; Gonzalez-Martin, A ; Schauer, C ; Fujiwara, K ; Vergote, I ; Colombo, N ; Pujade-Lauraine, E ; Treilleux, I ; Ray-Coquard, I

ELSEVIER SCIENCE INC

Texto completo disponível

Association of PD-L1 expression and gene expression profiling with clinical response to pembrolizumab in patients with advanced recurrent ovarian cancer: Results from the phase II KEYNOTE-100 study

Ledermann, JA ; Shapira-Frommer, R ; Santin, A ; Lisyanskaya, AS ; Pignata, S ; Vergote, I ; Raspagliesi, F ; Sonke, GS ; Birrer, MJ ; Provencher, DM ; Sehouli, J ; Colombo, N ; Gonzalez-Martin, A ; Oaknin, A ; Ottevanger, PB ; Rudaitis, V ; Cristescu, R ; Kobie, J ; Ruman, J ; Matulonis, UA

OXFORD UNIV PRESS

Texto completo disponível

NIRVANA-1: A multicentre randomized study comparing carboplatin-paclitaxel (CP) followed by niraparib (nira) to CP ebevacizumab (bev) followed by nira-bev in patients with FIGO stage III ovarian high-grade epithelial cancer and no residual disease after upfront surgery

Freyer, G ; Gonzalez Martin, AJ ; Raspagliesi, F ; Peron, J ; Van Nieuwenhuysen, E ; Hasegawa, K ; Lim, M-C ; Ray-Coquard, IL

ELSEVIER

Texto completo disponível

Final overall survival (OS) results from the phase III PAOLA1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC)

Nagao, S ; Harter, P ; Leary, A ; Cropet, C ; Pignata, S ; Fujiwara, K ; Gonzalez Martin, AJ ; Bogner, G ; Vergote, I ; Colombo, N ; Maenpaa, J ; Selle, F ; Schmalfeldt, B ; Scambia, G ; Guerra Alia, EM ; Lefeuvre-Plesse, C ; Belau, A ; Lortholary, A ; Gropp-Meier, M ; Pujade-Lauraine, E ; Ray-Coquard, I

ELSEVIER

Texto completo disponível

PRIMA/ENGOT-OV26/GOG-3012 study: Updated long-term PFS and safety

Gonzalez Martin, AJ ; Pothuri, B ; Vergote, IB ; Graybill, W ; Mirza, MR ; Mccormick, C ; Lorusso, D ; Freyer, G ; Backes, F ; Baumann, KH ; Redondo Sanchez, A ; Moore, RG ; Vulsteke, C ; O'Cearbhaill, RE ; Malinowska, I ; Shtessel, L ; Compton, N ; Monk, BJ

ELSEVIER

Texto completo disponível

Hayes Martin Lecture. Our AMES is true: how an old concept still hits the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer

Cady, B

Texto completo disponível

Intraparenchymal Convection Enhanced Delivery of AAV in Sheep to Treat Mucopolysaccharidosis IIIC

O'Leary, Claire ; Forte, Gabriella ; Mitchell, Nadia ; Youshani, Amir ; Dyer, Adam ; Welby, Martin ; Russell, Katharina ; Murray, Samantha ; Jolinon, Nelly ; Jones, Simon ; Stacey, Kevin ; Davis, Dan ; Henckaerts, Els ; Palmer, David ; Kamaly, Ian ; Bigger, Brian W

CELL PRESS

Texto completo disponível

Improving patient safety in Palestinian hospitals: a cross-sectional and retrospective chart review study

Najjar, Shahenaz ; Nafouri, Nashat ; Vanhaecht, Kris ; Euwema, Martin

The Lancet Publishing Group

Texto completo disponível

Through the looking glass: a personal view of the field of rehabilitation medicine. The 56th John Stanley Coulter Memorial Lecture

Grabois, Martin

Texto completo disponível